购物车
0
有库存
HIT220912920
 sdf 文件
结构编辑
类似物检索
HIT220912920
  • HIT ID:HIT220912920
  • Cas No:205535-74-6
  • 常用名:KR30031
  • IUPAC:1-(3-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}propyl)-4,5-dimethoxy-2,3-dihydro-1H-indene-1-carbonitrile
    IUPAC:1-(3-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}propyl)-4,5-dimethoxy-2,3-dihydro-1H-indene-1-carbonitrile
  • InChI key:InChIKey=VLSLFQMGJUJBQJ-UHFFFAOYSA-N
  • 分子式:C26H34N2O4
  • 分子量:438.568
  • 氢键供体数 (HBD):
  • 氢键受体数 (HBA):
  • LogP:
  • SMILES:COc1ccc(CCN(C)CCCC2(CCc3c2ccc(OC)c3OC)C#N)cc1OC
    SMILES:COc1ccc(CCN(C)CCCC2(CCc3c2ccc(OC)c3OC)C#N)cc1OC
  • KR30031 is a novel P-glycoprotein inhibitor with potential anticancer activity. KR30031 is a verapamil analog with fewer cardiovascular effects. The ability of KR-30031 to reduce this efflux transport is equal to that of verapamil, a well-known P-glycoprotein inhibitor. The bioavailability of paclitaxel could be enhanced by coadministration of a P-glycoprotein inhibitor, KR-30031.
市场产品/服务共显示1个结果
  • 供应商
    TargetMolSC
    规格
    货期
    6-8周
    纯度
    -
    ¥ 10,600.00
    1

寻找合适的化合物库

您无法确定哪种化合物库最适合您的项目?或者您需要定制解决方案?Anymole随时为您提供帮助。
电话:400820-0310
合作:info@screeningcompound.com
技术支持:tech@screeningcompound.com
客服:service@screeningcompound.com
TargetMol | Target Loading
正在加载 ~